The ICER review is in: hope amidst uncertainty.
J Manag Care Spec Pharm
; 28(1): 115-118, 2022 Jan.
Article
en En
| MEDLINE
| ID: mdl-34949117
ABSTRACT
DISCLOSURES No funding contributed to the writing of this commentary. Smith Begolka, Butler, and Guadalupe are salaried employees of the National Eczema Association, which has received grants and sponsorship awards from a variety of industry partners, including AbbVie, Eli Lilly, Incyte, LEO Pharma, Pfizer, Regeneron, and Sanofi. Smith Begolka has received grant funding from Pfizer and advisory board honoraria from Pfizer and Incyte. Butler and Guadalupe have received advisory board honoraria from Incyte.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Incertidumbre
/
Dermatitis Atópica
Límite:
Humans
País/Región como asunto:
America do norte
Idioma:
En
Revista:
J Manag Care Spec Pharm
Año:
2022
Tipo del documento:
Article
País de afiliación:
Canadá